SHAREHOLDER INFORMATION 2013 financial calendar Share listings 17 April 2012 final dividend ex-dividend date London Stock Exchange 19 April 2012 final dividend record date The Companys Ordinary Shares are admitted to the Ofcial List of 16 May Annual General Meeting the London Stock Exchange.
They are listed under EPIC HIK, SEDOL 23 May 2012 final dividend paid to shareholders B0LCW08 GB and ISIN GB00B0LCW083.
Further information on this market, its trading systems and current 21 August 2013 interim results and interim dividend announced trading in Hikma Pharmaceuticals PLC shares can be found on the 5 September 2013 interim dividend ex-dividend date London Stock Exchange website www.
7 September 2013 interim dividend record date 10 October 2013 interim dividend paid to shareholders Global Depository Receipts Provisional dates.
The Company also has listed Global Depository Receipts GDRs on the Nasdaq Dubai.
They are listed under EPIC HIK and ISIN US4312882081.
Further information on the Nasdaq Dubai, its trading Shareholding enquiries systems and current trading in Hikma Pharmaceuticals PLC GDRs can Enquiries or information concerning existing shareholdings should be be found on the website www.
directed to the Companys registrars, Capita Registrars either: American Depository Receipts ADRs 3 in writing to Shareholder Services, Capita Registrars, The Registry, Hikma Pharmaceuticals PLC has an ADR programme for which BNY 34 Beckenham Road, Beckenham, Kent BR3 4TU: Mellon acts as Depositary.
One ADR equates to 2 Hikma Ordinary 3 by telephone from within the UK on 0870 162 3100: Shares.
ADRs are traded as a Level 1 Over-the-Counter OTC 3 by telephone from outside the UK on 44 208 639 2157: or programme under the symbol HKMPY.
Enquiries should be made to: 3 through the website www.
BNY Mellon Shareowner Services PO Box 358516 Dividend payments Currency Pittsburgh, PA 15252-8516 The Company declares dividends in US Dollars.
Unless you have elected otherwise, you will receive your dividend in US Dollars.
Shareholders Tel: 1 201 680 6825 can opt to receive the dividend in Pounds Sterling or Jordanian Dinar.
Tel: 1 888 BNY ADRS toll-free within the US The Registrar retains records of the dividend currency for each E-mail: shrrelations@bnymellon.
com shareholder and only changes them at the shareholders request.
If you wish to change the currency in which you receive your dividend Shareholder fraud please contact the Registrars.
The Financial Services Authority has issued a number of warnings to shareholders regarding boiler room scams.
Over the last year many Dividend payments Bank Transfer companies have become aware that shareholders have received Shareholders who currently receive their dividend by cheque can unsolicited phone calls or correspondence concerning investment request a dividend mandate form from the Registrar and have their matters.
These are typically from overseas based brokers who target dividend paid direct into their bank account on the same day as the UK shareholders, offering to sell them what often turn out to be dividend is paid.
The tax voucher is sent direct to the shareholders worthless or high risk shares in US or UK investments.
are commonly known as boiler rooms.
These brokers can be very persistent and extremely persuasive.
Shareholders are advised to be very Dividend payments International Payment System cautious of unsolicited advice, offers to buy shares at a discount or offers If you are an overseas shareholder the Registrar is now able to pay of free Company reports.
If you receive any unsolicited investment advice: dividends in several foreign currencies for an administrative charge of 5.00, which is deducted from the payment.
Contact the Registrar obtain the correct name of the person and organisations: for further information.
check they are authorised by the FSA by looking the firm up on www.
uk register: Website report the matter to the FSA either by calling 0845 606 1234 or visit Press releases, the share price and other information on the Group www.
uk: are available on the Companys website www.
if the caller persists, hang up.
Details of the share dealing facilities sponsored by the Company are included in Company mailings and are on the Company website.
The Companys website is www.
com and the registered ofce is13 Hanover Square, London W1S 1HW.
164 HIKMA PHARMACEUTICALS PLC ANNUAL REPORT 2012
